Tricuspid Regurgitation Study
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 119 participants.
Also called NCT01093001
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 119 participants
- Sponsor
- Registry
-
NCT01093001
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01093001. Randomized; no masking; primary purpose prevention. Start 2010-05 (registry gives no type); primary completion 2015-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Tricuspid Regurgitation Study
- Condition
- Tricuspid Regurgitation
- Condition
- Right Ventricular Dysfunction
- Condition
- Left Ventricular Dysfunction
- Intervention (Other)
- Echo
- Intervention (Other)
- Echo
- Intervention (Other)
- Echo
- Intervention (Other)
- Echo
- Lead sponsor
- Mayo Clinic
- Collaborator
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct01093001- Content hash
442d00178bd2f24e25bd3d64e02ef9ede1735959e2f6018c221469dfa2a9078b